Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 1
1995 1
2000 1
2001 2
2003 1
2004 2
2005 1
2006 1
2007 2
2008 1
2009 2
2010 4
2011 2
2012 4
2013 6
2014 2
2015 3
2016 4
2017 3
2018 4
2020 5
2021 5
2022 4
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder"
Page 1
Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies.
Al-Mansour Z, Nelson BP, Evens AM. Al-Mansour Z, et al. Curr Hematol Malig Rep. 2013 Sep;8(3):173-83. doi: 10.1007/s11899-013-0162-5. Curr Hematol Malig Rep. 2013. PMID: 23737188 Free PMC article. Review.
Post-transplant lymphoproliferative diseases (PTLD) are heterogeneous lymphoid disorders ranging from indolent polyclonal proliferations to aggressive lymphomas that complicate solid organ or hematopoietic transplantation. ...Clinically, extra-nodal di
Post-transplant lymphoproliferative diseases (PTLD) are heterogeneous lymphoid disorders ranging from indolent p
Management of Non-Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder.
Major A, Kamdar M. Major A, et al. Curr Treat Options Oncol. 2018 May 24;19(7):33. doi: 10.1007/s11864-018-0549-6. Curr Treat Options Oncol. 2018. PMID: 29797086 Review.
Post-transplant lymphoproliferative disorder (PTLD) is one of the most common neoplasms seen after solid organ and hematopoietic stem cell transplantation, and is associated with significant morbidity and mortality. The pathogenesis is related to po
Post-transplant lymphoproliferative disorder (PTLD) is one of the most common neoplasms seen after solid organ a
Distinctive Clinicopathologic Features of Monomorphic B-cell Post-transplant Lymphoproliferative Disorders in Children.
Zhang Y, Mariani R, Gong M, Kirschmann D, Caparelli E, Wallace N, Turner R, Lu X, Gao J, Yap KL, Gong S. Zhang Y, et al. Pediatr Dev Pathol. 2021 Jul-Aug;24(4):318-326. doi: 10.1177/10935266211007254. Epub 2021 Apr 19. Pediatr Dev Pathol. 2021. PMID: 33872109
INTRODUCTION: Post-transplant lymphoproliferative disorders (PTLDs) comprise a heterogeneous group of Epstein-Barr virus (EBV)-positive or negative lymphoid or plasmacytic lesions in solid organ or hematopoietic stem cell (HSC) transplant recipients. . …
INTRODUCTION: Post-transplant lymphoproliferative disorders (PTLDs) comprise a heterogeneous group of Epstein-Ba …
Pediatric post-transplant lymphoproliferative disorder after cardiac transplantation.
Ohta H, Fukushima N, Ozono K. Ohta H, et al. Int J Hematol. 2009 Sep;90(2):127-136. doi: 10.1007/s12185-009-0399-x. Epub 2009 Aug 12. Int J Hematol. 2009. PMID: 19669857 Review.
Post-transplant lymphoproliferative disorder (PTLD) is a well recognized and potentially fatal complication after pediatric cardiac transplantation. PTLD encompasses a wide spectrum, ranging from benign hyperplasia to more aggressive lymphoma. Most cas
Post-transplant lymphoproliferative disorder (PTLD) is a well recognized and potentially fatal complication afte
Post-transplant Lymphoproliferative Disorder: A Single-Center Experience.
Ferreira H, Bustorff M, Santos J, Ferreira I, Sampaio S, Salomé I, Bastos J, Bergantim R, Príncipe F, Pestana M. Ferreira H, et al. Transplant Proc. 2015 May;47(4):981-4. doi: 10.1016/j.transproceed.2015.03.017. Transplant Proc. 2015. PMID: 26036499
BACKGROUND: Post-transplant lymphoproliferative disorder (PTLD) is the second most common neoplasia after adult kidney transplantation (KT). ...Three patients had previously received anti-thymocyte globulin/OKT3, and all were taking calcineurin inhibit …
BACKGROUND: Post-transplant lymphoproliferative disorder (PTLD) is the second most common neoplasia after adult …
Identification of high-risk monomorphic post-transplant lymphoproliferative disorder following solid organ transplantation.
Voorhees TJ, Kannan KK, Galeotti J, Grover N, Vaidya R, Moore DT, Montgomery ND, Beaven AW, Dittus C. Voorhees TJ, et al. Leuk Lymphoma. 2021 Jan;62(1):86-94. doi: 10.1080/10428194.2020.1821006. Epub 2020 Sep 16. Leuk Lymphoma. 2021. PMID: 32933363
Monomorphic post-transplant lymphoproliferative disorder (M-PTLD) occurring after solid organ transplant histologically resembles aggressive non-Hodgkin lymphomas, with diffuse large B-cell lymphoma being the most common. ...
Monomorphic post-transplant lymphoproliferative disorder (M-PTLD) occurring after solid organ transplant
Post-transplant lymphoproliferative disease in liver transplant recipients.
Rubio-Manzanares Dorado M, Álamo Martínez JM, Bernal Bellido C, Marín Gómez LM, Suárez Artacho G, Cepeda Franco C, Wang J, Gómez Bravo MÁ, Padillo FJ. Rubio-Manzanares Dorado M, et al. Rev Esp Enferm Dig. 2017 Jun;109(6):406-413. doi: 10.17235/reed.2017.4228/2016. Rev Esp Enferm Dig. 2017. PMID: 28508661 Free article.
INTRODUCTION: Post-transplant lymphoproliferative syndrome (PTLD) is a rare and potentially life-threatening complication after liver transplantation. ...PTLD localization was extranodal in all cases, the most frequent location being intestinal. Seven cases s …
INTRODUCTION: Post-transplant lymphoproliferative syndrome (PTLD) is a rare and potentially life-threatening complicati …
Real-world evidence of the safety and survival with CD19 CAR-T cell therapy for relapsed/refractory solid organ transplant-related PTLD.
McKenna M, Epperla N, Ghobadi A, Liu J, Lazaryan A, Ibrahim U, Jacobson CA, Naik SG, Nastoupil L, Chowdhury SM, Voorhees TJ, Jacobs MT, Farooq U, Osman K, Olszewski AJ, Ahmed S, Evens AM. McKenna M, et al. Br J Haematol. 2023 Jul;202(2):248-255. doi: 10.1111/bjh.18828. Epub 2023 May 2. Br J Haematol. 2023. PMID: 37129856
The use of CD19 chimeric antigen receptor T-cell (CAR-T) therapy for relapsed/refractory solid organ transplantation (SOT)-related post-transplant lymphoproliferative disorder (PTLD) is not well studied. ...Among 22 relapsed/refractory SOT-PTLD patient …
The use of CD19 chimeric antigen receptor T-cell (CAR-T) therapy for relapsed/refractory solid organ transplantation (SOT)-related post
A retrospective analysis of post-transplant lymphoproliferative disorder following liver transplantation.
Fararjeh FA, Mahmood S, Tachtatzis P, Yallop D, Devereux S, Patten P, Agrawal K, Suddle A, O'Grady J, Heaton N, Marcus R, Kassam S. Fararjeh FA, et al. Eur J Haematol. 2018 Jan;100(1):98-103. doi: 10.1111/ejh.12988. Epub 2017 Dec 4. Eur J Haematol. 2018. PMID: 29094407
OBJECTIVE: To evaluate response rates and survival in adults developing post-transplant lymphoproliferative disorder (PTLD) following liver transplantation. ...The median age at first transplant and at development of PTLD was 48 and 54 years, respectiv …
OBJECTIVE: To evaluate response rates and survival in adults developing post-transplant lymphoproliferative disorder
The diverse pathology of post-transplant lymphoproliferative disorders: the importance of a standardized approach.
Nalesnik MA. Nalesnik MA. Transpl Infect Dis. 2001 Jun;3(2):88-96. doi: 10.1034/j.1399-3062.2001.003002088.x. Transpl Infect Dis. 2001. PMID: 11395974 Review.
Post-transplant lymphoproliferative disorders (PTLD) are a diverse group of abnormal lymphoid growths that include both hyperplasias and neoplasias. ...These include early or hyperplastic PTLD, polymorphic PTLD, and lymphomatous or monomorphic P
Post-transplant lymphoproliferative disorders (PTLD) are a diverse group of abnormal lymphoid growths that inclu
54 results